Codexis acquires BioCatalytics to bolster enzyme manufacture
Redwood City, Calif.-based Codexis, a developer of enzyme-based manufacturing processes, said it acquired BioCatalytics, a Pasadena, Calif., producer of enzymes that speed chemical reactions. Terms of the deal weren’t disclosed; the release is here.
Both companies are focused on “biocatalysis,” a technique for using bioengineered and natural enzymes to accelerate chemical reactions, often improving their cleanliness and efficiency. Industry estimates suggest the enzyme market will expand to $2.2 billion in annual sales by 2010, up from $1.6 billion in 2005.
Next Story: Consumer product reviews: here, there, everywhere
Previous Story: Ablation Frontiers raises $22M for treating arrythmia
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.